Osteoporosis Medication Shows Benefits in Increasing Bone Density
Patients with osteoporosis got some good news at a recent conference when the results of a study showed that taking the drug denosumab can help increase bone density and keep their rate of fractures at a low level.
'Smart Capsule' Shows Potential in Weight Loss
A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.
Liraglutide Helps with Weight Loss and Delays Development of Type 2 Diabetes in Obese and Overweight Patients
Obese and overweight patients who were treated with the drug liraglutide experienced significant weight loss and were less likely to develop type 2 diabetes than patients who received placebo.
Research Shows Benefits of Diabetes Drug in Heart Disease
A drug which has already been approved for patients with diabetes could have more benefits for people at risk of having heart disease, according a recent study.
Bone Loss Remains Concern For Gastric Bypass Patients Following Surgery
A recent study of patients who underwent bariatric surgery showed that even while their weight settled following their procedure their bone loss continued even two years after the operation.
Gut Microbiome-altering Drug Could Offer New Treatment for Diabetes
An experimental, first-in-class drug that affects the gut microbiota has been shown to improve glucose tolerance and insulin sensitivity in adults with prediabetes.
Testosterone Levels Impact Restful Sleep for Obese, Overweight Men
A new factor in sleep and sleep apnea among obese and overweight men was introduced by researchers at a recent conference, pointing to the man's testosterone levels as helping determine sleep quality.
Gut Microbiota Linked to Diabetes and Obesity
Intestinal bacteria levels may be a good marker for determining risk of type 2 diabetes and obesity.
High Blood Glucose Levels Associated with Depression Risk in Patients with Type 1 Diabetes
The brains of hyperglycemic patients with Type 1 diabetes produce elevated levels of the neurotransmitter glutamate, which may increase their risk of depression.
Treatment with Empagliflozin Effectively Lowers Blood Pressure in Patients with Type 2 Diabetes and Hypertension
Treatment for 12 weeks with empagliflozin led to significant reductions in HbA1c levels and blood pressure compared to placebo.